Relentless. Passionate. Focused.

Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.

Our Story

Kiniksa has an experienced team with a track record of delivering therapies to patients. We have numerous product-candidates in both clinical and preclinical development across a range of debilitating diseases with significant unmet medical need.

Our Strategy

Identify and rapidly develop product candidates with clear biology, validated mechanisms and the potential to deliver life-changing improvement to patients

PatientFocus

ClearBiology

Rare/SpecialtyDiseases

RapidDevelopment

GlobalVision

3

clinical stage molecules

1

planned pivotal study in a rare, debilitating disease

2

molecules preparing for IND-enabling studies

3+

discovery-stage targets

80+

employees committed to helping patients